TRCT
BIOA

Tower Research Capital (TRC)’s BioAmber Inc. BIOA Stock Holding History

Tower Research Capital (TRC)’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-609
Closed -$1K – 4403
2017
Q2 		$1K Buy
+609
New +$1.4K ﹤0.01% 2591
2016
Q4 		– Sell
-4,319
Closed -$18K – 4824
2016
Q3 		$18K Buy
4,319
+2,567
+147% +$9.49K ﹤0.01% 1696
2016
Q2 		$5K Buy
1,752
+1,607
+1,108% +$5.86K ﹤0.01% 3462
2016
Q1 		$1K Buy
145
+45
+45% +$189 ﹤0.01% 3936
2015
Q4 		$1K Sell
100
-176
-64% -$1.33K ﹤0.01% 4286
2015
Q3 		$2K Buy
+276
New +$1.82K ﹤0.01% 3492
2015
Q1 		– Sell
-300
Closed -$3K – 5257
2014
Q4 		$3K Hold
300
– – ﹤0.01% 3218
2014
Q3 		$3K Sell
300
-2,480
-89% -$29K ﹤0.01% 3685
2014
Q2 		$28K Buy
2,780
+2,301
+480% +$23.8K ﹤0.01% 1652
2014
Q1 		$5K Sell
479
-621
-56% -$7.36K ﹤0.01% 3336
2013
Q4 		$8K Sell
1,100
-1,538
-58% -$10.5K ﹤0.01% 3238
2013
Q3 		$13K Buy
2,638
+938
+55% +$5.34K ﹤0.01% 3033
2013
Q2 		$12K Buy
+1,700
New +$12.6K ﹤0.01% 2230

Other funds holding BIOA

NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s BIOA Position: Q3 2017 in Review

Tower Research Capital (TRC) sold out of BioAmber Inc. (BIOA) in Q3 2017, closing a stake of 609 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in BIOA in Q2 2013 and held it in 13 quarters. The position peaked at $28K in Q2 2014. 30 funds tracked by Wall St. Rank hold BIOA as of Q3 2017.

  • Tower Research Capital (TRC) reported no remaining BioAmber Inc. position as of Q3 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 609 BioAmber Inc. shares in Q3 2017, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in BioAmber Inc. in Q2 2013 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s BioAmber Inc. position peaked at $28K in Q2 2014.
  • 30 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.